Introduction
============

*Pseudomonas aeruginosa* is one of the most common pathogens causing nosocomial infection with the high mortality rate \[[@R1]\], \[[@R2]\], \[[@R3]\]. The intrinsic resistance of *P. aeruginosa* to numerous antimicrobial agents and notable increasing of multi-drug resistance strains play an important role in high mortality rate in nosocomial infection \[[@R4]\], \[[@R5]\]. Moreover, it was shown that *P. aeruginosa* is an important pathogen causing severe infections in patients suffering from respiratory diseases, chemotherapy cancer patients, immunocompromised hosts and young adults with cystic fibrosis \[[@R6]\], \[[@R7]\], \[[@R8]\], \[[@R9]\]. *P. aeruginosa* is a highly adaptable microorganism and can develop resistance to different antibiotics. Multidrug-resistance (MDR) strains of *P. aeruginosa* use different mechanisms for developing resistance such as producing enzymes for inactivating β-lactams like ESBL (extended spectrum beta lactamase), MBL (metallo-β-lactamase) \[[@R10]\], \[[@R11]\], and biofilm formation can enhance ability of resistance in *P. aeruginosa* \[[@R12]\]. *P. aeruginosa* isolated from respiratory tract with typical non-mucoid phenotype, but in prolonged infection, can shift to mucoid form with producing large amounts of exopolysaccharide called alginate \[[@R13]\], \[[@R14]\]. Overexpression of alginate in mucoid strains forming micro-colonies which may be less susceptible to host defense mechanisms \[[@R15]\]. Mutation may induce mucoid variants, emerging within months of colonization. Thus, transition from early colonization to chronic infection may be associated with a change in *P. aeruginosa* phenotype from non-mucoid to mucoid colony formation \[[@R16]\]. The antimicrobial susceptibility pattern is different between mucoid and non-mucoid *P. aeruginosa* strains. It was suggested that biofilm formation of *P. aeruginosa* strains are more resistant to antibiotics; initially this resistance was related to mucoid strains. One hypothesis has been that glycocalyx can act like a major barrier to antibiotic diffusion because of its polyanionic characteristics \[[@R17]\], \[[@R18]\]. This hypothesis was refuted by the fact that some antibiotics such as tobramycin can bind to exopolysaccharide produced by *P. aeruginosa* \[[@R19]\].

The aim of this study was to determine the phenotypic type (mucoid/non-mucoid) of *P. aeruginosa* isolated from hospitalized patients in Milad and Mostafa Khomeini Hospitals in Tehran, Iran and to investigate the differences in antimicrobial susceptibility pattern among mucoid and non-mucoid isolates.

Materials and methods
=====================

One hundred *P. aeruginosa* were collected from two hospitals in Tehran. Eighty *P. aeruginosa* were isolated from hospitalized patients in Milad Hospital and 20 strains from patients referred to Mostafa Khomeini Hospital.

Biochemical and molecular identification of bacterial strains
-------------------------------------------------------------

Initial biochemical tests were performed to characterize *P. aeruginosa* such as growth on MacConkey agar medium, oxidase, catalase, urease, Sulfur Indole Motility test (SIM), triple sugar iron agar, oxidation/fermentation glucose, lysine decarboxylase, methyl red and Voges-Proskauer (MR-VP), Simmon citrate test, gelatin hydrolysis and growth at 42°C. The identity of isolates was confirmed using two specific sets of primers which amplify two outer membrane lipoproteins as described elsewhere \[[@R20]\]. PCR amplification of I lipoprotein (*oprl*) was performed for detection of genus and L lipoprotein (*oprL*) for detection of species of this organism. The sequences of primers are shown in Table 1 [(Tab. 1)](#T1){ref-type="fig"}. Bacterial DNA extraction was performed using boiling method and extracts of genomic DNA were subjected to PCR assay. PCR was performed in a reaction mixture with the total volume of 25 Il, containing 5 Il template DNA (20 ng), 2.5 Il 10X Taq polymerase buffer \[100 mM Tris/HCl (pH 8.3), 500 mM KCl, and 15 mM MgCl2\], 0.25 Il (100 pmol/ Il) each of primers, 0.25 Il dNTPs (10 mM), 0.2 Il (5U/ Il) Taq DNA polymerase and 16.55 Il sterilized distilled water. Amplification for *oprI* and *oprL* was done as follows: initial denaturation step at 93°C for 5 min followed by 30 cycles consisting of denaturation (93°C for 1 min), annealing (57°C for 1 min), and extension (72°C for 1 min), followed by a final extension step at 72°C for 10 min.

Differentiation of mucoid and non-mucoid strains
------------------------------------------------

Mucoid strains were identified using the Muir method as described elsewhere \[[@R21]\]. Briefly, for each of 100 isolates, a thin film of suspension was prepared and air-dried, the film was covered with a piece of filter paper and slide was flooded with Ziehl-Neelsen carbol fuchsin and heated to steaming for 30 seconds. The slide was gently rinsed with 95% ethanol and then with distilled water. Mordant solution was added for 20 seconds and then washed with distilled water followed by de-colorization step using ethanol. For counterstaining, 0.3% methylene blue was used for 30--60 seconds prior to examination of the preparations under the oil immersion lens. The cells were stained red, and the capsules blue.

Determination of biofilm formation by Congo red agar method (CRA)
-----------------------------------------------------------------

Biofilm formation was determined by the CRA method described elsewhere \[[@R22]\]. BHI agar medium was prepared and supplemented with 5% sucrose and 0.08% Congo red (Sigma-Aldrich, Germany). Congo red was prepared in form of concentrated aqueous solution and it was autoclaved at 121°C for 15 min, separately from other medium constituents. Following autoclave, the concentrated solution was added to agar which was previously cooled to 55°C. All 100 isolates were cultivated in streaks on prepared BHI agar medium and incubated aerobically at 37°C for 24--48 h.

Minimum inhibitory concentration (MIC)
--------------------------------------

Minimum inhibitory concentration (MIC) for 23 different antibiotics was performed for all 100 isolates using MIC sensititre susceptibility plates (TREK Diagnostic Systems, Cleveland, OH) according to instruction provided by the manufacturer. The bacterial suspension of isolates with final concentration of 105 CFU/ml was prepared and followed by manufacturer's instruction.

Statistical analysis
--------------------

The MICs of all tested antibiotics for mucoid and non-mucoid isolates were analyzed using SPSS software, version 17.0. The chi square of all antibiotics was determined between mucoid and non-mucoid isolates and p-value of less than 0.05 was considered significant.

Results
=======

Identification of isolates
--------------------------

One hundred isolates with yellow colonies on MacConkey agar medium, lactose --, oxidase +, Simmon citrate +, urease --, TSI (Alk/Alk), lysine decarboxylase --, oxidation of glucose +, MR --, VP --, gelatin hydrolysis + and growth on 42°C + were identified as *P. aeruginosa*. PCR assay confirmed the identification of isolates. Specific 249 and 504 bp bands were detected in all isolates which were corresponded to *oprI* and *oprL* gene and determine the *Pseudomonas* genus and *P. aeruginosa*, respectively (Figure 1 [(Fig. 1)](#F1){ref-type="fig"}).

Differentiation between mucoid and non-mucoid isolates
------------------------------------------------------

Phenotypic determination of mucoid and non-mucoid isolates was investigated by two phenotypic method, Muir mordant staining and Congo red agar assay. Half of the isolates (50%) were mucoid and 50% were non-mucoid. The mucoid strains showed red colonies and non-mucoid produced pink to white colonies on BHI agar containing Congo red and sucrose. Fourteen of 20 (70%) strains isolated from Mostafa Khomeini Hospital and 36 of 80 (45%) strains isolated from Milad Hospital were mucoid.

Antimicrobial susceptibility among mucoid and non-mucoid isolates
-----------------------------------------------------------------

Antimicrobial susceptibility pattern of mucoid and non-mucoid *P. aeruginosa* against 23 different tested antibiotics was determined (Table 2 [(Tab. 2)](#T2){ref-type="fig"}). Among mucoid isolates, high resistance corresponded to sulfisoxazole (100%), chloramphenicol (100%), co-trimoxazole (98%), tetracycline (98%) and ampicillin/sulbactam (96%). Whereas high resistance rate among non-mucoid isolates was seen in sulfisoxazole (100%), ampicillin/sulbactam (100%), co-trimoxazole (92%), cefotaxime (84%), chloramphenicol (98%), ceftriaxone (82%) and tetracycline (98%).

Statistical analysis of susceptibility patterns of mucoid and non-mucoid isolates
---------------------------------------------------------------------------------

Statistical analysis showed that non-mucoid isolates were significantly more resistant than mucoid type to β-lactams, aminoglycosides (such as amikacin, tobramycin and gentamicin) and quinolones (i.e., levofloxacin, ciprofloxacin, levofloxacin) (p\<0.05). While no significant difference was observed among mucoid and non-mucoid strains in resistance to other tested antibiotics (p\>0.05).

Discussion
==========

*P. aeruginosa* infection is a serious cause of nosocomial infection. This organism is adapted by forming biofilms in which the bacteria are protected from host defenses and antibiotics \[[@R23]\]. For instance, biofilm formation of mucoid *P. aeruginosa* strains is the main cause of lung infections in patients with cystic fibrosis. The results of this study indicated that amount of mucoid strains have been increased recently in Iran in contrast to previous studies \[[@R24]\]. According to previous studies it was thought that antimicrobial susceptibility patterns are different between mucoid and non-mucoid *P. aeruginosa* strains \[[@R6]\], \[[@R25]\], \[[@R26]\]. The results of this study showed that mucoid isolates were more susceptible to antibiotics which is consistent with findings of other studies from United States, Thailand \[[@R6]\], \[[@R26]\], \[[@R27]\].

One hypothesis suggests that the glycocalyx material itself usually acts as a polyanionic polysaccharide barrier to antibiotic diffusion \[[@R17]\], \[[@R18]\]. This was refuted by the fact that, although some antibiotics such as tobramycin binds to the exopolysaccharide produced by *P. aeruginosa*, the resulting reduction in diffusion coefficient of tobramycin within a colony or biofilm would not be enough to allow one to define the glycocalyx as a significant penetration barrier \[[@R28]\]. In the present study, 50% of *P. aeruginosa* isolates were identified as mucoid type. These findings showed the significant increase in mucoid form of *P. aeruginosa* in comparison with other studies in Iran (32%) and Thailand (3.6%) \[[@R6]\], \[[@R24]\]. The differences between antimicrobial susceptibility pattern among mucoid and non-mucoid types were more significant in β-lactams antibiotics (i.e. ceftazidime, piperacillin, cefoperazone, ticarcillin, cefepime and carbenicillin (p\<0.05). However, in other β-lactams (i.e., cefotaxime, ceftriaxone, aztreonam and imipenem) no significant differences were observed. The higher resistance to β-lactams among non-mucoid strains seen in this study is consistent with Ciofu et al. \[[@R29]\]. In Ciofu study, it was reported that non-mucoid isolates have more ability to produce β-lactamase and are exposed to a relatively higher antibiotic selective pressure than the mucoid type. This might be due to biofilm formation. The biofilm-embedded cells may have different antimicrobial susceptibility pattern depending on the site where each individual bacterial cell is located within the multiple layer of biofilm \[[@R30]\]. The β-lactamase produced by the superficial layer in the biofilm and will be able to inactive the β-lactam before reaching into the deep layers \[[@R31]\]. Mucoid and non-mucoid phenotypes can live in symbiosis within the biofilm. While the mucoid, alginate hyper-producing cells ensure the survival of the biofim, the non-mucoid cells might play protective role against antibiotics.

Resistance to quinolones and aminoglycosides was significant higher in non-mucoid*P. aeruginosa* isolates than mucoid types. There was no significant difference in resistance to tetracycline, chloramphenicol and cotrimoxazole among mucoid and non-mucoid isolates.

In summary, our findings show the mucoid isolates were generally more susceptible to antibiotics than non-mucoid *P. aeruginosa*. Regarding the importance of mucoid isolates in nosocomial infections among hospitalized patients specially patients with cystic fibrosis, differentiation between mucoid and non-mucoid isolates may play a major role in the prevention of nosocomial infections. The antimicrobial susceptibility pattern was significantly different between mucoid and non-mucoid *P. aeruginosa* isolates; these findings could enhance accurate diagnosis and proper antibiotic treatment in nosocomial infection cases. On the other hand, different antibiotic resistance patterns observed in this study could be association with different origin of these isolates which would require further investigation.
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![A) PCR amplification of *oprI* gene among suspected isolates for detection of *Pseudomonas* spp. M: 1kb DNA size marker; lane1: positive control *P. aeruginosa* ATCC 27853; lane; 2,3: suspected isolates.\
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